Article
Investigating Genetic Risk to Oxaliplatin-Induced Sinusoidal Obstruction Syndrome in Colorectal Cancer Through Routinely Available Next-Generation Sequencing Data.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 May 2026
Zhang Mengxue, Wang Peng, Kong Yang, Gaudio Daniela D, Parente Nick, Hayden Ashley, Setia Namrata, Hart John
Abstract excerpt
Sinusoidal obstruction syndrome (SOS) is a known adverse effect of oxaliplatin, causing significant morbidity and cessation of chemotherapy. Recent studies suggest single-nucleotide polymorphisms of certain genes may predispose carriers to oxaliplatin-induced liver toxicity. This study aims to evaluate candidate SOS-predisposing single-nucleotide polymorphisms by correlating routinely available next-generation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
